Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation

NCT00162487 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hyperkalemia
Chronic Renal Failure

Interventions

DRUG: Albuterol (1,200 μg) through metered-dose inhaler

Sponsor

Hadassah Medical Organization